Developer docs
API playgroundTry for free, no card

Search company profiles

Ximedica

Full company profile

uuid0009k3w

Namestring
Ximedica
Legal namestring
Ximedica LLC
Websiteurl
ximedica.com
Company typeenum
Private
Founded yearint
1991
Descriptiontext

Ximedica is a privately held, fully integrated medical device product development firm headquartered in Providence, Rhode Island. Founded in 1991 by two Rhode Island School of Design industrial designers, the company delivers end-to-end services across six core areas — Medical Technologies, Diagnostics, Digital, Design + Human Factors, Drug Delivery Systems, and Manufacturing — for clients ranging from startups to enterprise MedTech companies. Its technical platform is anchored by FDA-aligned design controls, ISO 13485:2016 certified quality management (including for Class III implantable devices), a 70,000 sq ft ISO Class 7 and Class 8 cleanroom manufacturing facility, dedicated human factors engineering compliant with IEC-62366, and a portfolio of 700+ patents developed across 30+ years of medical device innovation.

The business model combines project-based professional services fees (concept generation, design, engineering, regulatory documentation, human factors) with hardware revenue from contract manufacturing. Distribution is delivered through a direct enterprise sales motion supported by five regional offices (Providence, Philadelphia, Minneapolis, San Francisco, Hong Kong), industry conference participation (AdvaMed, AACC, HIMSS, SAGES, PODD), and thought-leadership content (blog, podcasts, webinars, case studies). Customer segments span medical device manufacturers, diagnostics companies, pharmaceutical/biotech firms developing combination products, and digital health companies. Since 2022, Ximedica has operated as a subsidiary of Veranex, an end-to-end MedTech services platform, with no public revenue disclosure and limited post-2014 funding visibility.

Short descriptiontext

Ximedica is a privately held medical device product development firm providing integrated design, engineering, regulatory, human factors, and contract manufacturing services for medical device, diagnostics, pharma/biotech, and digital health clients from concept through commercialization, now operating as a Veranex subsidiary.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
251–500
akta.pro rankint
HeadquartersProvidence, United States
HQ citystring
Providence
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices5 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
medical device development, medical device design, medical device manufacturing, human factors engineering, drug delivery systems
NAICS code2 codes
  • Surgical and Medical Instrument Manufacturing339112
  • Scientific Research and Development Services5417
SIC code1 code
  • Surgical & Medical Instruments & Apparatus3841
Product category
Medical Device Development Services
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Medical Device Development Services
TypeProfessional Services
Description

Project-based medical device design and development services from concept through regulatory submission, including research, prototyping, design controls, and manufacturing transfer.

ximedica.com
2Contract Manufacturing
TypeHardware Sales
Description

ISO 13485 certified manufacturing of complex medical devices including capital equipment, robotics, and FDA classified products. Services include production planning, quality engineering, process validation, and supply chain management.

ximedica.com
3Drug Delivery System Development
TypeProfessional Services
Description

Combination product development services for drug delivery systems including regulatory strategy, human factors, and material considerations for pharmaceutical and biotech partners.

ximedica.com
Marketing channels7 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels3 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Ximedica is a fully integrated medical device product development firm delivering end-to-end services from research and concept generation through design verification, regulatory submission, manufacturing transfer, and commercial support. The firm operates across six service areas — Medical Technologies, Diagnostics, Digital Health, Design + Human Factors, Drug Delivery Systems, and ISO 13485-certified Manufacturing — serving startups through large medical device companies on a project-based engagement model.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 2 values shown
  • Hundreds of satisfied clients in healthcare industry
+1 more record
Product overview1 text field

Ximedica is a medical device development company offering comprehensive end-to-end product development services from concept to commercialization. The company operates across six integrated service areas: Medical Technologies (surgical robotics, laparoscopic tools, catheter systems, infusion systems, diagnostic devices, and wearable sensors), Diagnostics (in vitro diagnostic platforms, point-of-care systems, and molecular diagnostics), Digital (connected health products, mobile applications, and data strategies), Design + Human Factors (human-centered design and usability engineering), Drug Delivery Systems (combination products, injection systems, and infusion devices), and Manufacturing (ISO-certified clean room assembly and scalable production). Now part of Veranex, Ximedica leverages a vertically integrated process with 30+ years of experience to deliver medical products that are designed, approved, manufactured, and commercially supported.

Product and service7 records
1Medical Technologies Development
CategoryMedical Device Design and Development
Description

Design and development services spanning surgical robotics, laparoscopic tools, catheter-based delivery systems, infusion systems, diagnostic devices, wearable sensors, and therapeutic devices for medical device companies.

2Diagnostics Development
CategoryIn Vitro Diagnostics Development
Description

In vitro diagnostic platform development including point-of-care systems, rapid molecular analysis, laboratory automation, biomarker and drug discovery tools, and microfluidics-based diagnostic instruments for IVD and life science companies.

3Digital Health Development
CategoryDigital Health Product Development
Description

Connected medical device development, mobile health applications, HIPAA-compliant cloud infrastructure, and data strategy services for digital health and connected device companies.

4Design + Human Factors
CategoryHuman Factors Engineering
Description

Human-centered design and human factors engineering services including concept generation, usability evaluations, participatory design, IFU design, anthropometric research, and regulatory documentation aligned with FDA guidance and IEC-62366.

5Drug Delivery Systems Development
CategoryDrug Delivery System Development
Description

Combination product development services for drug delivery systems including topical, transmucosal, respiratory/inhalation, transdermal, and injection-based delivery, patch pumps, mechanical and electromechanical infusion devices, and blood handling systems for pharmaceutical and biotech partners.

6Medical Device Manufacturing
CategoryContract Medical Device Manufacturing
Description

ISO 13485-certified contract manufacturing in a 70,000 sq ft facility with Class 7 and Class 8 cleanrooms, including production planning, quality engineering, process validation, cleanroom assembly and testing, sterilization management, and supply chain management.

7Surgical Robotics Platform Development
CategorySurgical Robotics Development
Description

Specialized surgical robotics platform development services including full-scale robotic platform design, instrument development, and speed-to-market solutions for robotic surgical system developers.

Scale indicator5 records

Each record includes

Type, Value, Description, Source

Partnership3 partners
Strategic tierMinorTypeGTM or Marketing PartnerAnnounced on2021-07-12
Description

Partnership with Red Crow, a digital crowdsourcing and funding platform focused on healthcare innovation. Ximedica offers office hours to RedCrow startups along with other select medtech partners including Experien Group, Alira Health, and Astella.

Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2021-04-01
Description

Ximedica announced partnership with Moderna to develop a prototype for rapid mobile manufacturing of vaccines and therapeutics as part of DARPA's Nucleic Acids On-Demand World-Wide (NOW) Program. This represents Ximedica's expertise in rapid manufacturing solutions.

Strategic tierCoreTypeStrategic or Co-development Partner
Description

Ximedica is now part of Veranex, an end-to-end service provider for medical device companies. Veranex provides integrated research, product development, regulatory, and manufacturing services, positioning Ximedica as part of a comprehensive MedTech solutions ecosystem.

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Market position
Competitive moat5 records

Each record includes

Type, Details

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile4 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance2 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds1 record

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors1 record

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A2 records

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Ximedica

Medical Device Development Servicesximedica.com

Ximedica is a privately held medical device product development firm providing integrated design, engineering, regulatory, human factors, and contract manufacturing services for medical device, diagnostics, pharma/biotech, and digital health clients from concept through commercialization, now operating as a Veranex subsidiary.

What Ximedica does

Ximedica is a privately held, fully integrated medical device product development firm headquartered in Providence, Rhode Island. Founded in 1991 by two Rhode Island School of Design industrial designers, the company delivers end-to-end services across six core areas — Medical Technologies, Diagnostics, Digital, Design + Human Factors, Drug Delivery Systems, and Manufacturing — for clients ranging from startups to enterprise MedTech companies. Its technical platform is anchored by FDA-aligned design controls, ISO 13485:2016 certified quality management (including for Class III implantable devices), a 70,000 sq ft ISO Class 7 and Class 8 cleanroom manufacturing facility, dedicated human factors engineering compliant with IEC-62366, and a portfolio of 700+ patents developed across 30+ years of medical device innovation.

The business model combines project-based professional services fees (concept generation, design, engineering, regulatory documentation, human factors) with hardware revenue from contract manufacturing. Distribution is delivered through a direct enterprise sales motion supported by five regional offices (Providence, Philadelphia, Minneapolis, San Francisco, Hong Kong), industry conference participation (AdvaMed, AACC, HIMSS, SAGES, PODD), and thought-leadership content (blog, podcasts, webinars, case studies). Customer segments span medical device manufacturers, diagnostics companies, pharmaceutical/biotech firms developing combination products, and digital health companies. Since 2022, Ximedica has operated as a subsidiary of Veranex, an end-to-end MedTech services platform, with no public revenue disclosure and limited post-2014 funding visibility.

Ximedica firmographics

Firmographics
Name
Ximedica
Legal name
Ximedica LLC
Website
https://ximedica.com
Company type
Private
Founded year
1991
Operating status
Operating
Headcount range
251–500 employees
Short description
Ximedica is a privately held medical device product development firm providing integrated design, engineering, regulatory, human factors, and contract manufacturing services for medical device, diagnostics, pharma/biotech, and digital health clients from concept through commercialization, now operating as a Veranex subsidiary.
Ownership category
akta.pro rank

Where Ximedica is headquartered

Location

Headquarters

HQ city
Providence
HQ country
United States
HQ region
North America

Offices5 records

Markets served

Ximedica business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

  1. Medical Device Development Services: Project-based medical device design and development services from concept through regulatory submission, including research, prototyping, design controls, and manufacturing transfer.
  2. Contract Manufacturing: ISO 13485 certified manufacturing of complex medical devices including capital equipment, robotics, and FDA classified products. Services include production planning, quality engineering, process validation, and supply chain management.
  3. Drug Delivery System Development: Combination product development services for drug delivery systems including regulatory strategy, human factors, and material considerations for pharmaceutical and biotech partners.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels7 records

Ximedica product offering

Product offering

Core offering

Ximedica is a fully integrated medical device product development firm delivering end-to-end services from research and concept generation through design verification, regulatory submission, manufacturing transfer, and commercial support. The firm operates across six service areas — Medical Technologies, Diagnostics, Digital Health, Design + Human Factors, Drug Delivery Systems, and ISO 13485-certified Manufacturing — serving startups through large medical device companies on a project-based engagement model.

Product overview

Ximedica is a medical device development company offering comprehensive end-to-end product development services from concept to commercialization. The company operates across six integrated service areas: Medical Technologies (surgical robotics, laparoscopic tools, catheter systems, infusion systems, diagnostic devices, and wearable sensors), Diagnostics (in vitro diagnostic platforms, point-of-care systems, and molecular diagnostics), Digital (connected health products, mobile applications, and data strategies), Design + Human Factors (human-centered design and usability engineering), Drug Delivery Systems (combination products, injection systems, and infusion devices), and Manufacturing (ISO-certified clean room assembly and scalable production). Now part of Veranex, Ximedica leverages a vertically integrated process with 30+ years of experience to deliver medical products that are designed, approved, manufactured, and commercially supported.

Differentiator

Problem solved

Functional benefit

Products and services

  • Medical Technologies Development Design and development services spanning surgical robotics, laparoscopic tools, catheter-based delivery systems, infusion systems, diagnostic devices, wearable sensors, and therapeutic devices for medical device companies.
  • Diagnostics Development In vitro diagnostic platform development including point-of-care systems, rapid molecular analysis, laboratory automation, biomarker and drug discovery tools, and microfluidics-based diagnostic instruments for IVD and life science companies.
  • Digital Health Development Connected medical device development, mobile health applications, HIPAA-compliant cloud infrastructure, and data strategy services for digital health and connected device companies.
  • Design + Human Factors Human-centered design and human factors engineering services including concept generation, usability evaluations, participatory design, IFU design, anthropometric research, and regulatory documentation aligned with FDA guidance and IEC-62366.
  • Drug Delivery Systems Development Combination product development services for drug delivery systems including topical, transmucosal, respiratory/inhalation, transdermal, and injection-based delivery, patch pumps, mechanical and electromechanical infusion devices, and blood handling systems for pharmaceutical and biotech partners.
  • Medical Device Manufacturing ISO 13485-certified contract manufacturing in a 70,000 sq ft facility with Class 7 and Class 8 cleanrooms, including production planning, quality engineering, process validation, cleanroom assembly and testing, sterilization management, and supply chain management.
  • Surgical Robotics Platform Development Specialized surgical robotics platform development services including full-scale robotic platform design, instrument development, and speed-to-market solutions for robotic surgical system developers.

Quantifiable outcome

  • Hundreds of satisfied clients in healthcare industry
  • +1 more outcomes

Companies that use Ximedica

Customer profile

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Ximedica technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

Ximedica partnerships and signals

Strategic signal

Partnerships

Three partnerships are on record, tiered minor and core.

  • Red CrowminorGTM or Marketing Partner · 12 July 2021Partnership with Red Crow, a digital crowdsourcing and funding platform focused on healthcare innovation. Ximedica offers office hours to RedCrow startups along with other select medtech partners including Experien Group, Alira Health, and Astella.
  • Moderna, Inc.coreStrategic or Co-development Partner · 1 April 2021Ximedica announced partnership with Moderna to develop a prototype for rapid mobile manufacturing of vaccines and therapeutics as part of DARPA's Nucleic Acids On-Demand World-Wide (NOW) Program. This represents Ximedica's expertise in rapid manufacturing solutions.
  • VeranexcoreStrategic or Co-development PartnerXimedica is now part of Veranex, an end-to-end service provider for medical device companies. Veranex provides integrated research, product development, regulatory, and manufacturing services, positioning Ximedica as part of a comprehensive MedTech solutions ecosystem.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Ximedica competitors and assessment

Company assessment

Market position

Competitive moat5 records

Key highlights7 records

Customer concentration

Ximedica social profiles

Digital presence

Ximedica compliance and trust

Trust signal

Compliance2 records

Ximedica financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Ximedica leadership team

Management profile

Number of profiles

Profiles1 record

Ximedica funding detail

Funding detail

Funding overview

Funding rounds1 record

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Ximedica M&A and investment

M&A and investment

M&A2 records

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Ximedica

What does Ximedica do?

Ximedica is a fully integrated medical device product development firm delivering end-to-end services from research and concept generation through design verification, regulatory submission, manufacturing transfer, and commercial support. The firm operates across six service areas — Medical Technologies, Diagnostics, Digital Health, Design + Human Factors, Drug Delivery Systems, and ISO 13485-certified Manufacturing — serving startups through large medical device companies on a project-based engagement model.

Is Ximedica a public or private company?

Ximedica is a private company. It is classified as corporate owned and is currently operating.

When was Ximedica founded?

Ximedica was founded in 1991. It employs 251 to 500 people.

Where is Ximedica based?

Ximedica is headquartered in Providence, United States, in the North America region.

How does Ximedica make money?

Three revenue lines are on record. Medical Device Development Services are the primary driver. The others are contract Manufacturing and drug Delivery System Development.

Does Ximedica have an API?

No public API is recorded for Ximedica.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
PR NewswireOutlook on the Product Design and Development Services Global Market to 2028 - Featuring Ximedica, DeviceLab, Jabil and Plexus Among OthersResearch and Markets has added a new market forecast report projecting the global product design and development services market to grow from approximately $9.5 billion in 2022 to $17.7 billion by 2028. The growth is primarily driven by technological advancements, such as AI in healthcare, and rising demand for quality medical products due to an aging global population. Key industry players profiled in the analysis include Ximedica, DeviceLab, Jabil, and Plexus.MedicaldesignandoutsourcingXimedica, Quartesian, Boston Healthcare Associates combine into VeranexPrivate equity firm Summit Partners has acquired Ximedica, Quartesian, and Boston Healthcare Associates to form a new medtech service company named Veranex. The Raleigh-based entity positions itself as the first concept-to-commercialization global service provider in the medtech sector, offering integrated design, regulatory, and market access capabilities. Veranex plans to pursue organic growth and further acquisitions to expand its platform and help clients accelerate time to market.PR NewswireXimedica announces partnership with Moderna, Inc. (Nasdaq: MRNA) to develop a prototype for rapid mobile manufacturing of vaccinesXimedica announced a partnership with Moderna, Inc. to develop a prototype for rapid mobile manufacturing of vaccines and therapeutics under DARPA's Nucleic Acids On-Demand World-Wide (NOW) Program. The four-year partnership will receive up to $11 million in funding, with the goal of creating a deployable manufacturing unit capable of producing hundreds of mRNA vaccine doses in a matter of days in remote locations worldwide. The initiative aims to provide near-instantaneous pandemic prevention treatments to both military personnel and local populations.PR NewswireXimedica responds to the current ventilator shortage by sponsoring the CoVent-19 challengeXimedica is sponsoring the CoVent-19 Challenge to expedite the development and approval of a ventilator design aimed at addressing the shortage caused by the COVID-19 pandemic. The challenge involves anesthesiology residents in Boston designing a minimum viable mechanical ventilator, with support from Ximedica's medical device development team. The initiative underscores the urgent need for innovation in ventilator production in response to the healthcare crisis.PR NewswireVitaHEAT Medical® and Ximedica Complete Initial Development Phase for the First Disposable Conductive Ink Patient Warming SystemVitaHEAT Medical and Ximedica have completed the initial development phase for a new disposable patient warming system utilizing patented conductive ink technology. This product aims to address safety concerns associated with traditional forced-air warming devices, which are currently dominant in the $1.8 billion global market but face litigation regarding infection risks.FinSMEsXimedica Receives Investment from SV Life SciencesXimedica, a Providence-based medical device product development firm, received a majority investment from SV Life Sciences. Co-founders Stephen Lane and Aidan Petrie sold their shares, with the amount undisclosed. SV Life Sciences' Paul LaViolette will join as chairman, while existing management remains.